The particular assay under consideration is designated as PUBCHEM_BIOASSAY: Navigating the Kinome, with its class being categorized as "other". The member assigned to the panel is referred to as MST1R, and the assay itself is designed to target a single protein homologously. Furthermore, this assay falls under the properties of being of the "other" assay category, with a functional description for its assay type. Can we confirm whether the molecule is having a positive impact on the outcome of this particular assay?